# Copernicus Capital Management, LLC

> Institutional holdings reported to the SEC as of Q3 2021 on Form 13F. CIK 1694620. Source: https://holderbook.com/funds/1694620-copernicus-capital-management-llc/

- Reported value: $8.3M
- Positions: 13
- Weight of the ten largest: 93.2%
- Filed: 2021-11-15

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| PFIZER INC | [PFE](https://holderbook.com/stocks/PFE/) | $1.3M | 30,000 | 15.6% | 1 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $1.1M | 2,000 | 13.8% | 1 |
| TELADOC HEALTH INC | [TDOC](https://holderbook.com/stocks/TDOC/) | $888.0K | 7,000 | 10.7% | 1 |
| BIOMARIN PHARMACEUTICAL INC | [BMRN](https://holderbook.com/stocks/BMRN/) | $850.0K | 11,000 | 10.3% | 1 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $808.0K | 5,000 | 9.8% | 1 |
| FATE THERAPEUTICS INC | [FATE](https://holderbook.com/stocks/FATE/) | $711.0K | 12,000 | 8.6% | 9 |
| HORIZON THERAPEUTICS PUB L | [HZNP](https://holderbook.com/stocks/HZNP/) | $657.0K | 6,000 | 8.0% | 2 |
| ARCUS BIOSCIENCES INC | [RCUS](https://holderbook.com/stocks/RCUS/) | $593.0K | 17,000 | 7.2% | 3 |
| ALLOGENE THERAPEUTICS INC | [ALLO](https://holderbook.com/stocks/ALLO/) | $386.0K | 15,000 | 4.7% | 1 |
| MEDTRONIC PLC | [MDT](https://holderbook.com/stocks/MDT/) | $376.0K | 3,000 | 4.6% | 1 |
| PROQR THRAPEUTICS N V | [PRQR](https://holderbook.com/stocks/PRQR/) | $335.0K | 40,000 | 4.1% | 1 |
| IMMATICS N.V | [IMTX](https://holderbook.com/stocks/IMTX/) | $130.0K | 10,000 | 1.6% | 1 |
| AMICUS THERAPEUTICS INC | [FOLD](https://holderbook.com/stocks/FOLD/) | $96.0K | 10,000 | 1.2% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2021 | -3.6% | +0.3% | -3.9% | 106% |
| Q2 2021 | -2.2% | +8.0% | -10.2% | 100% |
| Q1 2021 | -1.7% | +6.0% | -7.7% | 100% |
| Q4 2020 | +19.3% | +11.6% | +7.7% | 95% |
| Q3 2020 | +4.7% | +8.6% | -3.9% | 100% |
| Q2 2020 | +19.3% | +19.6% | -0.3% | 100% |
| Q1 2020 | -10.1% | -19.9% | +9.8% | 100% |
| Q4 2019 | +19.0% | +8.5% | +10.6% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2021 | $8.3M | 13 |
| Q2 2021 | $6.3M | 11 |
| Q1 2021 | $6.2M | 14 |
| Q4 2020 | $6.4M | 15 |
| Q3 2020 | $105.0M | 18 |
| Q2 2020 | $91.2M | 18 |
| Q1 2020 | $82.6M | 14 |
| Q4 2019 | $76.3M | 15 |
| Q3 2019 | $107.5M | 16 |
| Q2 2019 | $112.4M | 15 |
| Q1 2019 | $39.0M | 14 |
| Q4 2018 | $53.1M | 13 |